144 related articles for article (PubMed ID: 24935770)
1. The PHLDB1 rs498872 (11q23.3) polymorphism and glioma risk: A meta-analysis.
Gao X; Mi Y; Yan A; Sha B; Guo N; Hu Z; Zhang N; Jiang F; Gou X
Asia Pac J Clin Oncol; 2015 Dec; 11(4):e13-21. PubMed ID: 24935770
[TBL] [Abstract][Full Text] [Related]
2. Pleckstrin homology-like domain family B member 1 rs498872 polymorphism and glioma risk in Chinese Han population.
Zhang JW; Liu ZH; Lin XH; Du YP; Guo HT
Cell Mol Biol (Noisy-le-grand); 2017 Aug; 63(8):7-9. PubMed ID: 28886307
[TBL] [Abstract][Full Text] [Related]
3. The rs498872 polymorphism is associated with an elevated susceptibility to glioma: a meta-analysis of 36,264 subjects.
Chen B; Li Y; Chen L; Du Y
Acta Neurol Belg; 2019 Jun; 119(2):239-243. PubMed ID: 30684220
[TBL] [Abstract][Full Text] [Related]
4. CCDC26 rs4295627 polymorphism (8q24.21) and glioma risk: a meta-analysis.
Lu HW; Huang M; Wang JH; Sun XL; Ke YQ
Genet Mol Res; 2015 Oct; 14(4):12074-84. PubMed ID: 26505354
[TBL] [Abstract][Full Text] [Related]
5. Fine mapping of a region of chromosome 11q23.3 reveals independent locus associated with risk of glioma.
Chen H; Sun B; Zhao Y; Song X; Fan W; Zhou K; Zhou L; Mao Y; Lu D
PLoS One; 2012; 7(12):e52864. PubMed ID: 23300798
[TBL] [Abstract][Full Text] [Related]
6. Functional analysis of the 11q23.3 glioma susceptibility locus implicates PHLDB1 and DDX6 in glioma susceptibility.
Baskin R; Woods NT; Mendoza-Fandiño G; Forsyth P; Egan KM; Monteiro AN
Sci Rep; 2015 Nov; 5():17367. PubMed ID: 26610392
[TBL] [Abstract][Full Text] [Related]
7. Replication of GWAS identifies RTEL1, CDKN2A/B, and PHLDB1 SNPs as risk factors in Portuguese gliomas patients.
Viana-Pereira M; Moreno DA; Linhares P; Amorim J; Nabiço R; Costa S; Vaz R; Reis RM
Mol Biol Rep; 2020 Feb; 47(2):877-886. PubMed ID: 31721021
[TBL] [Abstract][Full Text] [Related]
8. Association of sequence variants on chromosomes 20, 11, and 5 (20q13.33, 11q23.3, and 5p15.33) with glioma susceptibility in a Chinese population.
Chen H; Chen Y; Zhao Y; Fan W; Zhou K; Liu Y; Zhou L; Mao Y; Wei Q; Xu J; Lu D
Am J Epidemiol; 2011 Apr; 173(8):915-22. PubMed ID: 21350045
[TBL] [Abstract][Full Text] [Related]
9. The CDKN2A-CDKN2B rs4977756 polymorphism and glioma risk: a meta-analysis.
Lu H; Yang Y; Wang J; Liu Y; Huang M; Sun X; Ke Y
Int J Clin Exp Med; 2015; 8(10):17480-8. PubMed ID: 26770338
[TBL] [Abstract][Full Text] [Related]
10. An Updated and Comprehensive Meta-Analysis of Association Between Seven Hot Loci Polymorphisms from Eight GWAS and Glioma Risk.
Wu Q; Peng Y; Zhao X
Mol Neurobiol; 2016 Sep; 53(7):4397-405. PubMed ID: 26243184
[TBL] [Abstract][Full Text] [Related]
11. Assessment of glioma risk associated with an inherited variant at chromosome 11q23.
Li Z; Wang Y; Guo X; Zhang L; Dong C; Zhang J
Cell Biochem Biophys; 2015 Jan; 71(1):69-75. PubMed ID: 25182002
[TBL] [Abstract][Full Text] [Related]
12. No association of the TGF-β1 29T/C polymorphism with breast cancer risk in Caucasian and Asian populations: evidence from a meta-analysis involving 55,841 subjects.
Alqumber MA; Dar SA; Haque S; Wahid M; Singh R; Akhter N
Asian Pac J Cancer Prev; 2014; 15(20):8725-34. PubMed ID: 25374198
[TBL] [Abstract][Full Text] [Related]
13. Association between the -159C/T polymorphism in the promoter region of the CD14 gene and sepsis: a meta-analysis.
Wu Q; Xu X; Ren J; Liu S; Liao X; Wu X; Hu D; Wang G; Gu G; Kang Y; Li J
BMC Anesthesiol; 2017 Jan; 17(1):11. PubMed ID: 28122493
[TBL] [Abstract][Full Text] [Related]
14. Association of XRCC3 Thr241Met polymorphisms and gliomas risk: evidence from a meta-analysis.
Liang HJ; Yan YL; Liu ZM; Chen X; Peng QL; Wang J; Mo CJ; Sui JZ; Wu JR; Zhai LM; Yang S; Li TJ; Li RL; Li S; Qin X
Asian Pac J Cancer Prev; 2013; 14(7):4243-7. PubMed ID: 23991984
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta1 polymorphisms and breast cancer risk: a meta-analysis based on 27 case-control studies.
Qi X; Zhang F; Yang X; Fan L; Zhang Y; Chen L; Zhou Y; Chen X; Zhong L; Jiang J
Breast Cancer Res Treat; 2010 Jul; 122(1):273-9. PubMed ID: 20309626
[TBL] [Abstract][Full Text] [Related]
16. Association between the XRCC1 polymorphisms and glioma risk: a meta-analysis of case-control studies.
Jiang L; Fang X; Bao Y; Zhou JY; Shen XY; Ding MH; Chen Y; Hu GH; Lu YC
PLoS One; 2013; 8(1):e55597. PubMed ID: 23383237
[TBL] [Abstract][Full Text] [Related]
17. Quantitative assessment of the association between XRCC3 C18607T polymorphism and glioma risk.
Wang R; Li M; Gao WW; Gu Y; Guo Y; Wang G; Tian HL
Tumour Biol; 2014 Feb; 35(2):1101-5. PubMed ID: 24186073
[TBL] [Abstract][Full Text] [Related]
18. Association of ERCC1 C8092A and ERCC2 Lys751Gln polymorphisms with the risk of glioma: a meta-analysis.
Xin Y; Hao S; Lu J; Wang Q; Zhang L
PLoS One; 2014; 9(4):e95966. PubMed ID: 24763305
[TBL] [Abstract][Full Text] [Related]
19. Genetic Polymorphisms of CCDC26 rs891835, rs6470745, and rs55705857 in Glioma Risk: A Systematic Review and Meta-analysis.
González-Castro TB; Juárez-Rojop IE; López-Narváez ML; Tovilla-Zárate CA; Genis-Mendoza AD; Pérez-Hernández N; Martínez-Magaña JJ; Rodríguez-Pérez JM
Biochem Genet; 2019 Aug; 57(4):583-605. PubMed ID: 30778791
[TBL] [Abstract][Full Text] [Related]
20. The RTEL1 rs6010620 polymorphism and glioma risk: a meta-analysis based on 12 case-control studies.
Du SL; Geng TT; Feng T; Chen CP; Jin TB; Chen C
Asian Pac J Cancer Prev; 2014; 15(23):10175-9. PubMed ID: 25556444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
